nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.508	1	CbGbCtD
Melphalan—L-Tyrosine—TAT—acquired immunodeficiency syndrome	0.00869	0.618	CrCbGaD
Melphalan—SLC7A5—retina—acquired immunodeficiency syndrome	0.00582	0.0975	CbGeAlD
Melphalan—SLC7A5—skin of body—acquired immunodeficiency syndrome	0.00511	0.0856	CbGeAlD
Melphalan—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.00504	0.359	CrCbGaD
Melphalan—SLC7A5—lymphoid tissue—acquired immunodeficiency syndrome	0.00414	0.0693	CbGeAlD
Melphalan—SLC7A5—digestive system—acquired immunodeficiency syndrome	0.00409	0.0684	CbGeAlD
Melphalan—SLC7A5—blood—acquired immunodeficiency syndrome	0.00389	0.0652	CbGeAlD
Melphalan—SLC7A5—bone marrow—acquired immunodeficiency syndrome	0.00377	0.0631	CbGeAlD
Melphalan—SLC7A5—spinal cord—acquired immunodeficiency syndrome	0.00375	0.0628	CbGeAlD
Melphalan—SLC7A5—vagina—acquired immunodeficiency syndrome	0.00361	0.0604	CbGeAlD
Melphalan—SLC7A5—lung—acquired immunodeficiency syndrome	0.00341	0.0572	CbGeAlD
Melphalan—SLC7A5—nervous system—acquired immunodeficiency syndrome	0.00316	0.0529	CbGeAlD
Melphalan—SLC7A5—central nervous system—acquired immunodeficiency syndrome	0.00304	0.051	CbGeAlD
Melphalan—SLC7A5—brain—acquired immunodeficiency syndrome	0.00242	0.0405	CbGeAlD
Melphalan—SLC7A5—lymph node—acquired immunodeficiency syndrome	0.00233	0.0391	CbGeAlD
Melphalan—SLC22A3—vagina—acquired immunodeficiency syndrome	0.00224	0.0375	CbGeAlD
Melphalan—SLC22A3—lung—acquired immunodeficiency syndrome	0.00212	0.0355	CbGeAlD
Melphalan—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.00196	0.0329	CbGeAlD
Melphalan—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.00189	0.0316	CbGeAlD
Melphalan—SLC22A3—brain—acquired immunodeficiency syndrome	0.0015	0.0251	CbGeAlD
Melphalan—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.00145	0.0243	CbGeAlD
Melphalan—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.00122	CcSEcCtD
Melphalan—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000511	0.00122	CcSEcCtD
Melphalan—Pain—Stavudine—acquired immunodeficiency syndrome	0.00051	0.00122	CcSEcCtD
Melphalan—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000507	0.00121	CcSEcCtD
Melphalan—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000507	0.00121	CcSEcCtD
Melphalan—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000506	0.00121	CcSEcCtD
Melphalan—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000506	0.00121	CcSEcCtD
Melphalan—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000503	0.0012	CcSEcCtD
Melphalan—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000503	0.0012	CcSEcCtD
Melphalan—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000503	0.0012	CcSEcCtD
Melphalan—Pain—Abacavir—acquired immunodeficiency syndrome	0.000502	0.0012	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000499	0.00119	CcSEcCtD
Melphalan—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000494	0.00118	CcSEcCtD
Melphalan—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000493	0.00118	CcSEcCtD
Melphalan—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000493	0.00118	CcSEcCtD
Melphalan—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000493	0.00118	CcSEcCtD
Melphalan—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.00118	CcSEcCtD
Melphalan—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000491	0.00117	CcSEcCtD
Melphalan—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.00117	CcSEcCtD
Melphalan—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000486	0.00116	CcSEcCtD
Melphalan—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000483	0.00116	CcSEcCtD
Melphalan—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.00115	CcSEcCtD
Melphalan—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000482	0.00115	CcSEcCtD
Melphalan—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000482	0.00115	CcSEcCtD
Melphalan—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000479	0.00115	CcSEcCtD
Melphalan—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000478	0.00114	CcSEcCtD
Melphalan—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.00114	CcSEcCtD
Melphalan—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00114	CcSEcCtD
Melphalan—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00114	CcSEcCtD
Melphalan—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000475	0.00114	CcSEcCtD
Melphalan—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000475	0.00114	CcSEcCtD
Melphalan—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000474	0.00113	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000472	0.00113	CcSEcCtD
Melphalan—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000472	0.00113	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00113	CcSEcCtD
Melphalan—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00047	0.00113	CcSEcCtD
Melphalan—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00047	0.00112	CcSEcCtD
Melphalan—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.00112	CcSEcCtD
Melphalan—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000468	0.00112	CcSEcCtD
Melphalan—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000467	0.00112	CcSEcCtD
Melphalan—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.00111	CcSEcCtD
Melphalan—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.00111	CcSEcCtD
Melphalan—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.00111	CcSEcCtD
Melphalan—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.0011	CcSEcCtD
Melphalan—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000459	0.0011	CcSEcCtD
Melphalan—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000456	0.00109	CcSEcCtD
Melphalan—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.00109	CcSEcCtD
Melphalan—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000455	0.00109	CcSEcCtD
Melphalan—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.00109	CcSEcCtD
Melphalan—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.00109	CcSEcCtD
Melphalan—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.00108	CcSEcCtD
Melphalan—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000448	0.00107	CcSEcCtD
Melphalan—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00107	CcSEcCtD
Melphalan—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00107	CcSEcCtD
Melphalan—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000446	0.00107	CcSEcCtD
Melphalan—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00106	CcSEcCtD
Melphalan—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000443	0.00106	CcSEcCtD
Melphalan—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00106	CcSEcCtD
Melphalan—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000442	0.00106	CcSEcCtD
Melphalan—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000442	0.00106	CcSEcCtD
Melphalan—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000441	0.00105	CcSEcCtD
Melphalan—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000439	0.00105	CcSEcCtD
Melphalan—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.00105	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000439	0.00105	CcSEcCtD
Melphalan—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000437	0.00105	CcSEcCtD
Melphalan—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000437	0.00104	CcSEcCtD
Melphalan—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000436	0.00104	CcSEcCtD
Melphalan—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00104	CcSEcCtD
Melphalan—Rash—Didanosine—acquired immunodeficiency syndrome	0.000433	0.00104	CcSEcCtD
Melphalan—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.00104	CcSEcCtD
Melphalan—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000433	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000433	0.00104	CcSEcCtD
Melphalan—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000433	0.00104	CcSEcCtD
Melphalan—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00103	CcSEcCtD
Melphalan—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00043	0.00103	CcSEcCtD
Melphalan—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000429	0.00103	CcSEcCtD
Melphalan—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00102	CcSEcCtD
Melphalan—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000428	0.00102	CcSEcCtD
Melphalan—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000427	0.00102	CcSEcCtD
Melphalan—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.00102	CcSEcCtD
Melphalan—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00102	CcSEcCtD
Melphalan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000424	0.00102	CcSEcCtD
Melphalan—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000423	0.00101	CcSEcCtD
Melphalan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000423	0.00101	CcSEcCtD
Melphalan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000423	0.00101	CcSEcCtD
Melphalan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000422	0.00101	CcSEcCtD
Melphalan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000421	0.00101	CcSEcCtD
Melphalan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00101	CcSEcCtD
Melphalan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00101	CcSEcCtD
Melphalan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000419	0.001	CcSEcCtD
Melphalan—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.001	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.000999	CcSEcCtD
Melphalan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000416	0.000996	CcSEcCtD
Melphalan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000416	0.000994	CcSEcCtD
Melphalan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000416	0.000994	CcSEcCtD
Melphalan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.000994	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000415	0.000993	CcSEcCtD
Melphalan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.000992	CcSEcCtD
Melphalan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000412	0.000986	CcSEcCtD
Melphalan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.000985	CcSEcCtD
Melphalan—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000412	0.000985	CcSEcCtD
Melphalan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000409	0.000979	CcSEcCtD
Melphalan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000409	0.000978	CcSEcCtD
Melphalan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000408	0.000976	CcSEcCtD
Melphalan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000408	0.000976	CcSEcCtD
Melphalan—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000407	0.000974	CcSEcCtD
Melphalan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.000971	CcSEcCtD
Melphalan—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.000971	CcSEcCtD
Melphalan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000968	CcSEcCtD
Melphalan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000968	CcSEcCtD
Melphalan—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000403	0.000964	CcSEcCtD
Melphalan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000402	0.000962	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.000961	CcSEcCtD
Melphalan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.000959	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.00095	CcSEcCtD
Melphalan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.000947	CcSEcCtD
Melphalan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000946	CcSEcCtD
Melphalan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000395	0.000944	CcSEcCtD
Melphalan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.000941	CcSEcCtD
Melphalan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000393	0.000941	CcSEcCtD
Melphalan—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000393	0.00094	CcSEcCtD
Melphalan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000393	0.00094	CcSEcCtD
Melphalan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000393	0.000939	CcSEcCtD
Melphalan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000391	0.000936	CcSEcCtD
Melphalan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.000936	CcSEcCtD
Melphalan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000389	0.000932	CcSEcCtD
Melphalan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000389	0.000932	CcSEcCtD
Melphalan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000389	0.000931	CcSEcCtD
Melphalan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000388	0.000929	CcSEcCtD
Melphalan—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.000928	CcSEcCtD
Melphalan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.000923	CcSEcCtD
Melphalan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.000923	CcSEcCtD
Melphalan—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.000922	CcSEcCtD
Melphalan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.000919	CcSEcCtD
Melphalan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000384	0.000918	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.000917	CcSEcCtD
Melphalan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000383	0.000916	CcSEcCtD
Melphalan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00038	0.00091	CcSEcCtD
Melphalan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00038	0.000909	CcSEcCtD
Melphalan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000379	0.000907	CcSEcCtD
Melphalan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.000906	CcSEcCtD
Melphalan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000377	0.000902	CcSEcCtD
Melphalan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000377	0.000901	CcSEcCtD
Melphalan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.000901	CcSEcCtD
Melphalan—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000377	0.000901	CcSEcCtD
Melphalan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.0009	CcSEcCtD
Melphalan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000376	0.0009	CcSEcCtD
Melphalan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.000899	CcSEcCtD
Melphalan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000376	0.000899	CcSEcCtD
Melphalan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000374	0.000894	CcSEcCtD
Melphalan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.000892	CcSEcCtD
Melphalan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00089	CcSEcCtD
Melphalan—Rash—Abacavir—acquired immunodeficiency syndrome	0.00037	0.000886	CcSEcCtD
Melphalan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00037	0.000885	CcSEcCtD
Melphalan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.000885	CcSEcCtD
Melphalan—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.000885	CcSEcCtD
Melphalan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.000885	CcSEcCtD
Melphalan—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.000879	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.000878	CcSEcCtD
Melphalan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000367	0.000878	CcSEcCtD
Melphalan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000367	0.000877	CcSEcCtD
Melphalan—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.000867	CcSEcCtD
Melphalan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000362	0.000867	CcSEcCtD
Melphalan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.000866	CcSEcCtD
Melphalan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.000866	CcSEcCtD
Melphalan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00086	CcSEcCtD
Melphalan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.00086	CcSEcCtD
Melphalan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000355	0.00085	CcSEcCtD
Melphalan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000355	0.00085	CcSEcCtD
Melphalan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.000849	CcSEcCtD
Melphalan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000355	0.000848	CcSEcCtD
Melphalan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000354	0.000847	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.000845	CcSEcCtD
Melphalan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.000844	CcSEcCtD
Melphalan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.000838	CcSEcCtD
Melphalan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000349	0.000835	CcSEcCtD
Melphalan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.000833	CcSEcCtD
Melphalan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.000832	CcSEcCtD
Melphalan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.000831	CcSEcCtD
Melphalan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.000828	CcSEcCtD
Melphalan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000346	0.000827	CcSEcCtD
Melphalan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.000827	CcSEcCtD
Melphalan—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000346	0.000827	CcSEcCtD
Melphalan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.000824	CcSEcCtD
Melphalan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.000817	CcSEcCtD
Melphalan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000341	0.000816	CcSEcCtD
Melphalan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.000807	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.000807	CcSEcCtD
Melphalan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000336	0.000803	CcSEcCtD
Melphalan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.000801	CcSEcCtD
Melphalan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.0008	CcSEcCtD
Melphalan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.000795	CcSEcCtD
Melphalan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000794	CcSEcCtD
Melphalan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.000789	CcSEcCtD
Melphalan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00033	0.000789	CcSEcCtD
Melphalan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00033	0.000788	CcSEcCtD
Melphalan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000327	0.000782	CcSEcCtD
Melphalan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.000782	CcSEcCtD
Melphalan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000326	0.000781	CcSEcCtD
Melphalan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.000779	CcSEcCtD
Melphalan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.000771	CcSEcCtD
Melphalan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00077	CcSEcCtD
Melphalan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000321	0.000768	CcSEcCtD
Melphalan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.000766	CcSEcCtD
Melphalan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.000764	CcSEcCtD
Melphalan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.000763	CcSEcCtD
Melphalan—Ibuprofen—ALB—acquired immunodeficiency syndrome	0.000317	0.0226	CrCbGaD
Melphalan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.000757	CcSEcCtD
Melphalan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.000748	CcSEcCtD
Melphalan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000312	0.000746	CcSEcCtD
Melphalan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.000738	CcSEcCtD
Melphalan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000737	CcSEcCtD
Melphalan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.000737	CcSEcCtD
Melphalan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000306	0.000733	CcSEcCtD
Melphalan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000304	0.000727	CcSEcCtD
Melphalan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000304	0.000726	CcSEcCtD
Melphalan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.000713	CcSEcCtD
Melphalan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00071	CcSEcCtD
Melphalan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000703	CcSEcCtD
Melphalan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.000693	CcSEcCtD
Melphalan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000692	CcSEcCtD
Melphalan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.000687	CcSEcCtD
Melphalan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.000686	CcSEcCtD
Melphalan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000286	0.000685	CcSEcCtD
Melphalan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.000684	CcSEcCtD
Melphalan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.000682	CcSEcCtD
Melphalan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.000666	CcSEcCtD
Melphalan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.000663	CcSEcCtD
Melphalan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.00066	CcSEcCtD
Melphalan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.000657	CcSEcCtD
Melphalan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000657	CcSEcCtD
Melphalan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.000657	CcSEcCtD
Melphalan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.000652	CcSEcCtD
Melphalan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.000647	CcSEcCtD
Melphalan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.000635	CcSEcCtD
Melphalan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.000635	CcSEcCtD
Melphalan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.000626	CcSEcCtD
Melphalan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.000619	CcSEcCtD
Melphalan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.000613	CcSEcCtD
Melphalan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.000608	CcSEcCtD
Melphalan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.000607	CcSEcCtD
Melphalan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000606	CcSEcCtD
Melphalan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00059	CcSEcCtD
Melphalan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000585	CcSEcCtD
Melphalan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000585	CcSEcCtD
Melphalan—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000573	CcSEcCtD
Melphalan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.000563	CcSEcCtD
Melphalan—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000558	CcSEcCtD
Melphalan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000558	CcSEcCtD
Melphalan—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000551	CcSEcCtD
Melphalan—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000526	CcSEcCtD
